BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31352641)

  • 21. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis.
    Abe JI; Ko KA; Kotla S; Wang Y; Paez-Mayorga J; Shin IJ; Imanishi M; Vu HT; Tao Y; Leiva-Juarez MM; Thomas TN; Medina JL; Won JH; Fujii Y; Giancursio CJ; McBeath E; Shin JH; Guzman L; Abe RJ; Taunton J; Mochizuki N; Faubion W; Cooke JP; Fujiwara K; Evans SE; Le NT
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway.
    Lian JH; Wang WH; Wang JQ; Zhang YH; Li Y
    Asian Pac J Cancer Prev; 2013; 14(9):5017-21. PubMed ID: 24175769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-211-5p Suppresses Metastatic Behavior by Targeting SNAI1 in Renal Cancer.
    Wang K; Jin W; Jin P; Fei X; Wang X; Chen X
    Mol Cancer Res; 2017 Apr; 15(4):448-456. PubMed ID: 28057716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.
    Breuksch I; Welter J; Bauer HK; Enklaar T; Frees S; Thüroff JW; Hasenburg A; Prawitt D; Brenner W
    Cell Commun Signal; 2018 Jun; 16(1):35. PubMed ID: 29954386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.
    Kantar D; Mur EB; Mancini M; Slaninova V; Salah YB; Costa L; Forest E; Lassus P; Géminard C; Boissière-Michot F; Orsetti B; Theillet C; Colinge J; Benistant C; Maraver A; Heron-Milhavet L; Djiane A
    Sci Rep; 2021 Mar; 11(1):5752. PubMed ID: 33707576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
    Xue S; Wang S; Li J; Guan H; Jiang S; Guo Y; Li Q
    IUBMB Life; 2019 Nov; 71(11):1720-1728. PubMed ID: 31298469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.
    Kalogirou C; Schäfer D; Krebs M; Kurz F; Schneider A; Riedmiller H; Kneitz B; Vergho D
    Urol Int; 2016; 96(1):106-15. PubMed ID: 26496641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions.
    Wörthmüller J; Rüegg C
    Cells; 2021 Jun; 10(6):. PubMed ID: 34198584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN.
    Schneider E; Keppler R; Prawitt D; Steinwender C; Roos FC; Thüroff JW; Lausch E; Brenner W
    Int J Oncol; 2011 Mar; 38(3):823-31. PubMed ID: 21206972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.